CareDxvsMerck & Company

CDNA and MRK stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$146.78

Value $363B

-0.88%
MRK's page

CareDx (CDNA) has a market value of $3.8B and Merck & Company (MRK) $363B. Over the last year, with dividends, CDNA moved +366.4% and MRK +62.6%. The P/E is 29.6 for CDNA and 147.9 for MRK. Dividend yield: CDNA none, MRK 2.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CDNA$3.8B

    MRK$363B

    MRK is 95 times CDNA

  • Revenue, 12 months

    CDNA$497M

    MRK$67.4B

    MRK is 135 times CDNA

  • Net income, 12 months

    CDNA$129M

    MRK$2.5B

    MRK is 19 times CDNA

  • Operating margin

    CDNA23.4%

    MRK–

  • ROIC

    CDNA25.3%

    MRK3.9%

    21.4 points apart

  • P/E

    CDNA29.6

    MRK147.9

    MRK is 5.0 times CDNA

  • Dividend yield

    CDNA0.0%

    MRK2.3%

    2.3 points apart

  • 5-year return

    CDNA+58.2%

    MRK+104.3%

    46.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CDNA+58.2%

MRK+104.3%

010020020222023202420252026
Returns by period
PeriodCDNAWith dividendsMRKWith dividends
1 year since November 14, 2025+366.4%Price +366.4%+62.6%Price +58.0%
3 years since November 16, 2023+714.2%+101.2% a yearPrice +714.2%+57.7%+16.4% a yearPrice +43.9%
5 years since November 15, 2021+58.2%+9.6% a yearPrice +58.2%+104.3%+15.4% a yearPrice +75.4%
10 years since November 16, 2016+2,119.1%+36.3% a yearPrice +2,119.1%+233.3%+12.8% a yearPrice +145.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CDNACareDxMRKMerck & Company

Valuation

CDNAMRK
Valuation
Price$74.34$146.78
Market value$3.8B$363B
Enterprise value (EV)$3.6B$407B
P/E29.6147.9
P/E, 5-year median–14.8
P/B8.18.1
EV/EBIT30.585.5
Free cash flow yield–4.1%

Results and growth

CDNAMRK
Results and growth
Revenue, 12 months$497M$67.4B
Net income, 12 months$129M$2.5B
Free cash flow, 12 months–$14.7B
Earnings per share, 12 months$2.39$0.98
Revenue growth, year on year13.8%1.3%
Revenue growth a year, past+14.6%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

CDNAMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin23.4%–
Net margin25.9%3.6%
ROIC25.3%3.9%
ROE35.3%5.2%

Balance sheet

CDNAMRK
Balance sheet
Cash$250M$9.7B
Total debt$29M$53.8B
Net debt / EBITDA-1.95.7
Interest cover–2.4×

Dividends and buybacks

CDNAMRK
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield2.3%1.4%
Shareholder yield2.3%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CDNA or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, CareDx or Merck & Company?

By market value, Merck & Company ($363B) is about 95.3 times CareDx ($3.8B), at today's prices.

How did CDNA and MRK stock do over the last 10 years?

Since November 16, 2016, CDNA's price moved +2,119.1% and MRK's +145.6%. With dividends: CDNA +2,119.1% (+36.3% a year), MRK +233.3% (+12.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, CDNA or MRK?

The dividend yield at today's price is none for CareDx and 2.32% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of CDNA and MRK?

At today's price, the P/E is 29.6 for CDNA and 147.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, CareDx or Merck & Company?

Over the last twelve months, the net margin was 25.9% for CareDx and 3.6% for Merck & Company, and the operating margin 23.4% and –. Revenue was $497M and $67.4B.

Which is the better investment, CareDx or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.